Francois Lebel
Director Técnico/Científico/I+D en SIRNAOMICS LTD. .
Perfil
Francois Lebel is currently the Chief Medical Officer at Sirnaomics Ltd.
He previously held positions as Vice President-Research & Development at Baxter International, Inc. from 2011 to 2012, Chief Medical Officer & Executive Vice President at Spectrum Pharmaceuticals, Inc. from 2018 to 2022, Chief Medical Officer and EVP-Research & Development at Alaunos Therapeutics, Inc. from 2013 to 2018, and Vice President-Medical & Scientific Affairs at Medimmune, Inc. from 2004 to 2006.
Dr. Lebel obtained undergraduate and doctorate degrees from the University of Ottawa.
Cargos activos de Francois Lebel
| Empresas | Cargo | Inicio |
|---|---|---|
| SIRNAOMICS LTD. | Director Técnico/Científico/I+D | 28/07/2023 |
Antiguos cargos conocidos de Francois Lebel.
| Empresas | Cargo | Fin |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 31/12/2022 |
| ALAUNOS THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 26/10/2018 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/07/2012 |
| Medimmune, Inc. | Director Técnico/Científico/I+D | 01/09/2006 |
Formación de Francois Lebel.
| University of Ottawa | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| SIRNAOMICS LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Medimmune, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Francois Lebel
